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Participation in diagnostic microbiology internal and external quality control (QC) processes is good
laboratory practice and an essential component of a quality management system. However, no QC scheme for
diagnostic oral microbiology existed until 2009 when the Clinical Oral Microbiology (COMB) Network was
created. At the European Oral Microbiology Workshop in 2008, 12 laboratories processing clinical oral
microbiological samples were identified. All these were recruited to participate into the study and six
laboratories from six European countries completed both the online survey and the first QC round. Three
additional laboratories participated in the second round. Based on the survey, European oral microbiology
laboratories process a significant (mean per laboratory 4,135) number of diagnostic samples from the oral
cavity annually. A majority of the laboratories did not participate in any internal or external QC programme
and nearly half of the laboratories did not have standard operating procedures for the tests they performed. In
both QC rounds, there was a large variation in the results, interpretation and reporting of antibiotic
susceptibility testing among the laboratories. In conclusion, the results of this study demonstrate the need for
harmonisation of laboratory processing methods and interpretation of results for oral microbiology
specimens. The QC rounds highlighted the value of external QC in evaluating the efficacy and safety of
processes, materials and methods used in the laboratory. The use of standardised methods is also a
prerequisite for multi-centre epidemiological studies that can provide important information on emerging
microbes and trends in anti-microbial susceptibility for empirical prescribing in oro-facial infections.
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I
nfections of the oral mucosa, teeth (caries and root
canal infections) and their supporting structures
(periodontitis, dento-alveolar abscess) are polymicro-
bial, although usually associated with a characteristic
microbiota linked to the site of infection (1). However,
identification of the relevant oral pathogens is not
commonly undertaken in diagnostic clinical microbiology
laboratories due to lack of expertise in handling fasti-
dious oral microbes and interpretation of the findings.
When specimens from oral diseases are processed, they
are frequently reported as ‘mixed oral flora’. This type of
reporting is unhelpful both to clinicians and to epide-
miologists collating data for disease and anti-microbial
susceptibility trends. This probably reflects the lack of
input by experts in oral microbiology into general guide-
lines for processing and reporting samples from the oral
cavity. Although there is a general consensus within the
dental and maxillo-facial surgery community on the role
of the major pathogens for many types of infection, there
is controversy on the role of some species, first line
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Furthermore, there is poor uptake and understanding of
microbiology diagnostic services by the dental profession,
inappropriate specimens and misinterpretation of culture
results (2, 3).
Microbiological diagnostics relies on the quality of the
test performance. This can be assured by internal
controls: testing the ability to culture, identify and
determine the anti-microbial profiles for indicator micro-
organisms with known susceptibility profiles. Standard
operating procedures (SOPs) and internal audits further
improve the accuracy and quality of the laboratory
performance. However, such data must be laboratory
independent, and exposure to external audits and quality
control (QC) rounds is essential. There are proficiency
schemes available for clinical microbiology laboratories
such as the United Kingdom National External Quality
Assessment Service (UK NEQAS; http://www.ukneqas-
micro.org.uk) and the Quality Control for Molecular
Diagnostics (QCMD; http://www.qcmd.org) for general
microbiology. However, external QC schemes for diag-
nostic oral microbiology are not available in any of the
European countries. To fulfil the requirements of diag-
nostic laboratory accreditation, the adoption of an
external QC process is mandatory in many countries. In
the 2008 European tri-annual meeting of oral microbiol-
ogy specialists (European Oral Microbiology Workshop
2008, Helsinki, Finland), a number of diagnostic oral
microbiology laboratories agreed to participate in the
collation of data from diagnostic laboratory processes,
interpretative criteria and quality assurance. The Clinical
Oral Microbiology (COMB) Network was created to
provide external QC rounds for member laboratories and
to collaborate on SOPs for processing and reporting
samples from the oral cavity.
The aim of this study was to evaluate the range of oral
infection specimens processed, diagnostic methods, inter-
nal and external QC programmes used in European
diagnostic oral microbiology laboratories by an online
questionnaire. In addition, we determined the perfor-
mance of respondent European oral microbiology diag-
nostic laboratories in processing and reporting blinded
spiked oral specimens from hypothetical oral disease
scenarios.
Materials and methods
At the European Oral Microbiology Workshop 2008
(EOMW2008), Helsinki, Finland, 12 laboratories proces-
sing clinical oral microbiological samples were identified.
All these were recruited to participate in the study and
seven originating from six European countries completed
both the online survey and the first QC round. Three
additional laboratories participated in the second QC
round.
Survey
The online survey consisted of a total of 18 open and
closed questions on the numbers and types of specimens
processed, molecular methods used, SOPs and participa-
tion in internal and external QC. The link to the survey
was sent to representatives of all 12 laboratories identified
at the EOMW 2008 meeting.
First QC round
A periodontal pocket QC specimen was prepared by
spiking sub-gingival plaque from a healthy volunteer
with the following pathogens: Aggregatibacter actinomy-
cetemcomitans, Porphyromonas gingivalis and Parvimonas
micra. The QC specimen (approximately 10
10 cfu/mL)
was prepared in thioglycolate broth of which 100 ml was
transferred into anaerobically prepared 2 ml VMGAIII
transport medium vials (4) and sent to participating
laboratories by a courier. The specimen was accompa-
nied with the following information: ‘The specimen is
from a 7 mm periodontal pocket, upper 1
st molar in a
56-year old male patient with type II diabetes and is
allergic to penicillin’. Participants were asked to analyse
the specimens using their normal SOPs and methods.
Laboratories were also asked to perform antibiotic
susceptibility tests on significant isolates. Information
on the assays, culture techniques and media used, as well
as transportation time, were recorded in a standardised
data collection sheet. A copy of a standard report was
also collated. The laboratory providing the round
cultured a control sample after 3 days of storage at
room temperature.
Second QC round
An endodontic QC specimen was prepared into Luria-
Bertani broth, Lennox (BD Difco, Sparks, MD, USA) by
spiking with an Escherichia coli (NCTC 13353; extended
spectrum beta-lactamase, extended spectrum beta-lacta-
mase (ESBL) positive), alpha haemolytic streptococci
(non-speciated) and Fusobacterium nucleatum (final con-
centration approximately 10
10 cfu/mL). Three paper
points (#50) were soaked in the spiked broth and
transferred into VMGAIII transport medium vial (4)
and sent to participating laboratories by a courier. The
specimen was accompanied with the following informa-
tion: ‘Root treatment started four days ago (old filling fell
out one month ago), now a flare up, lots of pus from root
canals. Patient has chronic obstructive pulmonary disease
(COPD) and is allergic to penicillin’. The laboratories
were asked to analyse and report the specimens as
previously. The laboratory providing the round cultured
a control sample after 3 days of storage at room
temperature.
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Survey
Based on the survey questionnaire, each laboratory
processed, on average, a total of 4,135 samples per
annum. Five of the seven laboratories (71%) did not
participate in any internal or external QC programme,
and three (43%) of the participating laboratories did not
have SOPs for the tests they performed. The numbers and
types of samples processed by the participant laboratories
are summarised in Fig. 1. The most common sample type
processed was sub-gingival plaque from patients with
various forms of periodontal disease: mean 3,037 sam-
ples/laboratory annually (range 1016,000). All labora-
tories processed these samples. Other clinical samples
processed were mucosal swabs, pus swabs and aspirates
(from dento-alveolar infections) in addition to perform-
ing dental caries susceptibility tests using stimulated
saliva as a clinical specimen. However, the mean annual
numbers for these were low: mean 118, 68, 77 and 134
samples/laboratory annually, respectively (range 0400).
First QC round
Six laboratories processed, analysed and reported the
sample within the specified time of 3 weeks. The mean
transportation time was 1.8 (13) days. The methods used
for anaerobic culture included conventional or fastidious
anaerobe blood agar (usually Columbia agar base
supplemented with defibrinated horse or sheep blood
(5%), haemin (5 mg/l) and menadione (110 mg/l)), and
on selective media, such as tryptic soy serum bacitracin
vancomycin agar (TSBV) for the cultivation of A.
actinomycetemcomitans (5). Two laboratories used
PCR techniques. One laboratory used a Real-Time
PCR-panel for periodontal pathogens (6, 7). Another
laboratory used conventional PCR with agarose gel
electrophoresis (8).
The findings reported by the laboratories are listed in
Table 1. Six laboratories reported one or more period-
ontal pathogens from the sample. The predominant
pathogens (A. actinomycetemcomitans, P. gingivalis)
were identified by three of six laboratories. The most
commonly identified finding was A. actinomycetemcomi-
tans (five of six laboratories). P. gingivalis and P. micra
were recovered by three of six laboratories. One labora-
tory reported that periodontal pathogens were not found.
Three laboratories identified and reported a number of
oral streptococci. The laboratory providing the round
detected all spiked pathogens.
Five laboratories performed susceptibility testing pri-
marily by disc diffusion. There was large variation in the
antibiotic susceptibility testing performed. Most often
susceptibility testing was performed for A. actinomyce-
temcomitans (n4) (Table 2). It was reported susceptible
to penicillin (two of three), amoxicillin (three of three)
and doxycycline/tetracycline (three of four) and resistant
Fig. 1. Proportion of participant laboratories (n6) that processed the indicated samples (hatched bars and upper x-axis) on a
routine basis and annual mean number of samples processed by the laboratories (solid bars and lower x-axis).
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of three IR). One laboratory reported that the isolate
was susceptible to metronidazole and two laboratories
reported that the isolate was resistant to metronidazole.
Second QC round
Nine laboratories processed and reported the sample
within the specified time of 3 weeks. The mean transpor-
tation time was 3.6 (26) days. All nine laboratories had
identified a heavy growth of a coliform. Six of these
identified the coliform as Escherichia coli and five
identified it as an ESBL producer. In addition, one
laboratory which did not name the coliform to species
level identified it as an ESBL producer. The E. coli was
identified by VITEK (n3) or by biochemical tests (one
by API 20E and one using API 32E (Biomerieux, La
Balme Les Grottes, France) and one not specified) (n
3). One laboratory reported that VITEK 2 had flagged
the E. coli as O157 requiring referral to a reference
laboratory, and no further processing of the sample was
carried out due to infection control guidance. Two of the
six laboratories that identified the ESBL-producing E.
coli highlighted the need to implement infection control
precautions in their report. Four laboratories isolated and
identified the alpha haemolytic streptococci to species
level and three of these reported anti-microbial suscept-
ibility data on this isolate. One laboratory reported the
isolate resistant to penicillin by disc diffusion. None of
the laboratories recovered and identified Fusobacterium
nucleatum. The laboratory providing the round detected
all spiked pathogens.
Discussion
Participation in diagnostic microbiology internal and
external QC processes is good laboratory practice and
an essential component of laboratory quality manage-
ment system. In many European countries, it is compul-
sory for all diagnostic laboratories to participate.
However, no QC scheme for diagnostic oral microbiology
Table 1. Isolates recovered by culture techniques and species identiﬁed by PCR from the Round 1 sub-gingival plaque sample
spiked with Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis and Parvimonas micra analysed by six
independent laboratories from six European countries
Culture techniques PCR
Laboratory 1 2 3 4 5 6 1 4
Isolate Percentage of total flora Semi quantitative amount PCR signal
Streptococcus agalactiae 
Streptococcus sanguis 
Streptococcus sp. 
Abiotrpohia adjacens 
Actinomyces odontolyticus 
Aggregatibacter actinomycetemcomitans 0.5 2.0 1.6   
Porphyromonas gingivalis 80.9 10.0 31.0  
Porphyromonas sp. 
Parvimonas micra 4.1 7.0 0.5 
Tannerella forsythia 0.7 0 0 
Fusobacterium nucleatum 0.15 
Fusobacterium sp. 
Prevotella intermedia/nigrescens 0 B0.01 0 
Prevotella melaninogenica 
Prevotella sp. 
Veillonella sp. 
Total bacterial count (cfu/ml) 5.510
7 110
8 1.110
7
Transportation time 1 day 2 days 3 days 1 day 1 day 1 day
Table 2. Antibiotograms reported for A. actinomycetemco-
mitans by four participant laboratories (S, susceptible; I,
intermediate; R, resistant)
AB
LAB Pen Amox Ery Clinda Doxy/tet Met Amox-Cla
1S S S
2S S I R SR S
4R R R S R
5S S I R R
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The results of this study show that European microbiol-
ogy laboratories process a significant number of diag-
nostic samples from the oral cavity annually. At the same
time, the majority of the surveyed laboratories did not
participate in any internal or external QC programme
and nearly half of the laboratories did not have SOPs for
the tests they performed.
Laboratories reported that they all processed period-
ontitis samples routinely. Therefore, it was decided to
provide a periodontitis QC specimen in the first instance.
Most of the laboratories were able to recover the
microaerophilic A. actinomycetemcomitans by culture.
However, only half of the laboratories recovered and
identified the anaerobic pathogens in the specimen. The
two PCR methods used by the laboratories in this study
appeared to be equally sensitive in detecting the patho-
gens. Interestingly, Tannerella forsythia was detected by
one of the PCR methods. The sample was not spiked with
this pathogen, but it is possible that it was present in low
numbers in the sub-gingival plaque from the healthy
volunteer used in preparation of the sample. Therefore, it
is possible that not all samples had detectable amounts of
T. forsythia. Other laboratories identified and reported a
number of facultative commensals of dental plaque as
pathogens reflecting lack of consensus regarding the
causality of the disease. These results highlighted the
challenges of recovering and identifying anaerobic bac-
teria by culture methods.
The results of the second round endodontic QC
specimen from a COPD patient also highlighted the
challenges of anaerobe diagnostics because no laboratory
was able to recover the F. nucleatum from the sample. A
high inoculum of E. coli may have inhibited or masked
the growth of F. nucleatum. All nine laboratories reported
heavygrowth of a coliform, six of which identified it as an
ESBL producer. However, only two of these laboratories
highlighted the need to take infection control precautions
in their report. Many hospitals make every effort to
isolate patients colonised with resistant pathogens,
although guidelines vary nationally. Both laboratories
that mentioned the need for infection control measures
were attached to larger general microbiology laboratories.
Updating and maintaining quality is a major challenge
for small isolated laboratories. Open access guidelines
and SOPs for processing and reporting oral samples
would provide minimum level of standardisation. This
QC highlighted the importance of knowledge of current
anti-microbial susceptibility mechanisms linked to infec-
tion prevention issues.
In both QC rounds, there was large variation in the
results, interpretation and reporting of antibiotic suscept-
ibility testing among the laboratories. This is not
surprising considering the various methodologies and
media used. In addition, there are no clinically proven
break points for a number of oral pathogens, and
interpretation is frequently based on the literature from
structurally similar pathogens resulting in discordant
results. This highlights the importance of closer coopera-
tion between diagnostic oral microbiology laboratories
within Europe. Considering the large number of patients
with oro-facial infections, it is disappointing that use of
diagnostic microbiology facilities is not utilised to a
greater extent. One of the challenges in working in the
speciality of diagnostic oral microbiology is the relatively
small numbers of laboratories undertaking such work in
Europe. This QC has demonstrated the importance of
closer collaborative working not just only for SOPs and
reporting but also for training and developing a con-
census in clinical interpretation of results and commu-
nication to clinicians and other medical microbiology
colleagues.
In conclusion, the results of this study demonstrate the
need for harmonisation of laboratory processing methods
and interpretation of results for oral microbiology speci-
mens. The use of standardised methods is also a
prerequisite for multi-centre epidemiological studies that
can provide important information on emerging microbes
and trends in anti-microbial susceptibility for empirical
prescribing in oro-facial infections. The results of the QC
rounds also highlighted the value of external QC in
evaluating the efficacy and safety of processes, materials
and methods used in the laboratory. Historically, anae-
robic culture methods are recognised as the gold standard
and molecular methods as a second line alternative (9
11). The results of these QC rounds should trigger a
critical evaluation of the sensitivity and reliability of the
culture methods used for the detection of anaerobic oral
bacteria. This exercise has also fostered collaborations
between a network of reference laboratories in the EU
identifying and characterising relevant pathogens from
oral infections, this should also provide a useful resource
for diagnostic medical microbiology laboratories.
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